LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Edwards Lifesciences Corp

Chiusa

SettoreSettore sanitario

77.57 -0.12

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

76.74

Massimo

77.74

Metriche Chiave

By Trading Economics

Entrata

-28M

358M

Vendite

27M

1.4B

P/E

Media del settore

32.273

51.198

EPS

0.64

Margine di Profitto

25.342

Dipendenti

15,800

EBITDA

-50M

434M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+5.82% upside

Dividendi

By Dow Jones

Utili prossimi

23 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1.1B

46B

Apertura precedente

77.69

Chiusura precedente

77.57

Notizie sul Sentiment di mercato

By Acuity

39%

61%

126 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bearish Evidence

Edwards Lifesciences Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 lug 2024, 13:57 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences to Buy Innovalve for $300 Million

25 ott 2024, 09:10 UTC

Utili

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25 ott 2024, 08:35 UTC

Utili

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3 set 2024, 20:38 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 set 2024, 20:37 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 set 2024, 20:36 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 lug 2024, 09:02 UTC

Utili
Azioni calde

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 lug 2024, 08:40 UTC

Notizie principali

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 lug 2024, 20:17 UTC

Utili

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 lug 2024, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 lug 2024, 20:15 UTC

Utili

Edwards Lifesciences 2Q Sales $1.39B >EW

24 lug 2024, 20:15 UTC

Utili

Edwards Lifesciences 2Q Net $366.3M >EW

24 lug 2024, 20:15 UTC

Utili

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 lug 2024, 20:15 UTC

Utili

Edwards Lifesciences 2Q EPS 61c >EW

15 lug 2024, 13:42 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences to Buy Innovalve for $300M

15 lug 2024, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 lug 2024, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 lug 2024, 13:00 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 lug 2024, 13:00 UTC

Acquisizioni, Fusioni, Takeovers

Edwards Lifesciences To Acquire Innovalve >EW

Confronto tra pari

Modifica del prezzo

Edwards Lifesciences Corp Previsione

Obiettivo di Prezzo

By TipRanks

5.82% in crescita

Previsioni per 12 mesi

Media 82.3 USD  5.82%

Alto 95 USD

Basso 75 USD

Basato su 15 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Edwards Lifesciences Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

15 ratings

7

Acquista

8

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

74.52 / 75.54Supporto e resistenza

A breve termine

Weak Bearish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

126 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.